TrovaGene Inc. (TROV) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TrovaGene Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 653,994 265,665 257,696 450,404 259,246
Cost of Goods Sold (COGS) incl. D&A 54,554 8,388 10,285 37,842 -
COGS excluding D&A 0 0 0 0 -
Depreciation & Amortization Expense 54,554 8,388 10,285 37,842 130,520
Depreciation 54,554 8,388 10,285 37,842 -
Amortization of Intangibles 0 0 0 0 -
Gross Income 599,440 257,277 247,411 412,562 -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.01M 2.61M 3.22M 5.26M 10.82M
Research & Development 562,212 1.02M 910,685 1.92M 3.95M
Other SG&A 1.45M 1.59M 2.31M 3.34M 6.87M
Other Operating Expense 0 0 0 0 0
Unusual Expense 814,920 2.62M (865,847) 6.72M 1.08M
EBIT after Unusual Expense (814,920) (2.62M) 865,847 (6.72M) (1.08M)
Non Operating Income/Expense 0 0 0 4,000 (22,941)
Non-Operating Interest Income 0 182 171 0 3,663
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 260,567 478,229 128,427 - 17,005
Gross Interest Expense 260,567 478,229 128,427 - 17,005
Interest Capitalized 0 0 0 0 0
Pretax Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 -
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic 0 0 0 0 -
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Preferred Dividends 38,240 38,240 38,240 38,240 29,840
Net Income Available to Common (2.52M) (5.49M) (2.28M) (11.6M) (11.84M)
EPS (Basic) (0.60) (0.78) (0.24) (0.89) (0.70)
Basic Shares Outstanding 5.2M 7.16M 9.71M 13.07M 16.98M
EPS (Diluted) (0.60) (0.78) (0.24) (0.89) (0.70)
Diluted Shares Outstanding 5.2M 7.16M 9.71M 13.07M 16.98M
EBITDA (1.35M) (2.34M) (2.97M) (4.81M) (10.56M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for TrovaGene Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 653,994 265,665 257,696 450,404 259,246
Cost of Goods Sold (COGS) incl. D&A 54,554 8,388 10,285 37,842 -
COGS excluding D&A 0 0 0 0 -
Depreciation & Amortization Expense 54,554 8,388 10,285 37,842 130,520
Depreciation 54,554 8,388 10,285 37,842 -
Amortization of Intangibles 0 0 0 0 -
Gross Income 599,440 257,277 247,411 412,562 -
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 2.01M 2.61M 3.22M 5.26M 10.82M
Research & Development 562,212 1.02M 910,685 1.92M 3.95M
Other SG&A 1.45M 1.59M 2.31M 3.34M 6.87M
Other Operating Expense 0 0 0 0 0
Unusual Expense 814,920 2.62M (865,847) 6.72M 1.08M
EBIT after Unusual Expense (814,920) (2.62M) 865,847 (6.72M) (1.08M)
Non Operating Income/Expense 0 0 0 4,000 (22,941)
Non-Operating Interest Income 0 182 171 0 3,663
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 260,567 478,229 128,427 - 17,005
Gross Interest Expense 260,567 478,229 128,427 - 17,005
Interest Capitalized 0 0 0 0 0
Pretax Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 0 -
Income Tax - Current Foreign 0 0 0 0 -
Income Tax - Deferred Domestic 0 0 0 0 -
Income Tax - Deferred Foreign 0 0 0 0 -
Income Tax Credits 0 0 0 0 -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Minority Interest Expense 0 0 0 0 0
Net Income (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (2.48M) (5.45M) (2.24M) (11.57M) (11.81M)
Preferred Dividends 38,240 38,240 38,240 38,240 29,840
Net Income Available to Common (2.52M) (5.49M) (2.28M) (11.6M) (11.84M)
EPS (Basic) (0.60) (0.78) (0.24) (0.89) (0.70)
Basic Shares Outstanding 5.2M 7.16M 9.71M 13.07M 16.98M
EPS (Diluted) (0.60) (0.78) (0.24) (0.89) (0.70)
Diluted Shares Outstanding 5.2M 7.16M 9.71M 13.07M 16.98M
EBITDA (1.35M) (2.34M) (2.97M) (4.81M) (10.56M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
